Literature DB >> 20110706

Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.

Akiko Shiotani1, Ryuji Nishi, Noriya Uedo, Hiroyasu Iishi, Hideaki Tsutsui, Manabu Ishii, Hiroshi Imamura, Tomoari Kamada, Jiro Hata, Ken Haruma.   

Abstract

BACKGROUND/AIMS: CDX2 is associated with the intestinal phenotype in the gastrointestinal tracts and is expressed in the intestinal type of gastric cancer. Helicobacter pylori-associated atrophic gastritis is characterized by aberrant expression of CDX2. The aim was to investigate the effects of eradication to the expression of genes related to the gastric and intestinal phenotype including CDX2. We compared the effect of eradication between the patients at high risk for gastric cancer and controls.
METHODS: 20 patients with endoscopic resection for early gastric cancer and 12 sex- and age-matched controls were studied. CDX2 and mucin mRNA expressions were examined using whole biopsy specimens and microdissected gastric glands taken from corpus lesser and greater curves before and 1 year after eradication.
RESULTS: CDX2 and MUC2 expressions in the cancer group were significantly higher than in the controls and were significantly decreased after eradication. MUC5AC (p = 0.01) and MUC6 (p = 0.02) expression significantly increased in the control group; the difference between the two groups became significant after eradication. CDX2 expression in the glands without goblet cells was detectable and disappeared after eradication.
CONCLUSION: H. pylori eradication can reverse gastric phenotype and diminish aberrant CDX2 expression in the early stage of intestinalization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20110706     DOI: 10.1159/000264651

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  5 in total

1.  Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression.

Authors:  Su Young Ahn; Sun-Young Lee; Sung Noh Hong; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Choon Jo Jin; Hye Seung Han
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

2.  H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands.

Authors:  Akiko Shiotani; Noriya Uedo; Hiroyasu Iishi; Takahisa Murao; Tomoko Kanzaki; Yoshiki Kimura; Tomoari Kamada; Hiroaki Kusunoki; Kazuhiko Inoue; Ken Haruma
Journal:  J Gastroenterol       Date:  2012-03-01       Impact factor: 7.527

3.  Advances in gastric cancer prevention.

Authors:  Antonio Giordano; Letizia Cito
Journal:  World J Clin Oncol       Date:  2012-09-10

4.  The co-expression of functional gastric proteins in dynamic gastric diseases and its clinical significance.

Authors:  Qian Xu; Li-Ping Sun; Ben-Gang Wang; Jing-Wei Liu; Ping Li; Cai-Yun He; Yuan Yuan
Journal:  BMC Clin Pathol       Date:  2013-08-09

Review 5.  Pathogenesis and risk factors for gastric cancer after Helicobacter pylori eradication.

Authors:  Reina Ohba; Katsunori Iijima
Journal:  World J Gastrointest Oncol       Date:  2016-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.